The Possible Role of Antibiotic-Modified Microbiome in the Development and Proliferation of Non-Communicable Diseases

A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiotics Use and Antimicrobial Stewardship".

Deadline for manuscript submissions: closed (31 October 2021) | Viewed by 290

Special Issue Editor

School of Medicine, Dept. of Migration Health, University of Pécs, Pécs, Hungary
Interests: infectious diseases; tropical diseases; antibiotics; antibiotic consumption; microbiome; microbiome and diseases; antibiotic-consumption related non-contagious diseases
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The discovery and extensive utilization of antibiotics has greatly contributed to the considerable lengthening of human life expectancy. The addition of antibiotics to animal fodder was found to have a considerable growth-promoting effect, and hence extended the indications of antibiotics  at a much higher level. The indiscriminate use of antibiotics quickly resulted in the emergence of poly-resistant pathogens and the extensive antibiotic pollution of the environment, particularly of the surface water through human and animal excreta. Along with extensive and ever-increasing antibiotic consumption/pollution, the pandemic-like  spreading of certain non-contagious diseases like obesity, diabetes (type 1 and 2 diabetes mellitus—T1DM, T2DM), Alzheimer’s disease, Parkinson’s disease, multiple  sclerosis, autism, and different malignancies, among others, started unfolding, which has been referred to as a slow-moving disaster, without any appropriate explanation of the phenomenon. The parallel appearance of these “pandemics”, which appeared simultaneously with the extensive antibiotic consumption, might indicate some kind of association. As far as several publications have reported, the crucial role of altered gut flora in the development of metabolic disorders (diabetes, obesity, etc.) and neurodegenerative diseases etc., it  might be suspected that antibiotics, acting through the modification of microbiome and the gut–brain axis, could influence the morbidity (prevalence) of these  non-infectious diseases, serving as a unified explanation for the phenomenon.

Prof. Dr. Gábor Ternák
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop